{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:49:46Z","timestamp":1790754586418,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","surgpath.theclinics.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.path.2018.02.005","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T18:07:35Z","timestamp":1525802855000},"page":"403-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["Cholangiocarcinoma"],"prefix":"10.1016","volume":"11","author":[{"given":"Alyssa M.","family":"Krasinskas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.path.2018.02.005_bib1","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.path.2018.02.005_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.path.2018.02.005_bib3","unstructured":"Kakar S, Shi C, Berlin J, et\u00a0al. Protocol for the examination of specimens from patients with carcinoma of the distal extrahepatic bile ducts. 2017. Available at: http:\/\/www.cap.org\/ShowProperty?nodePath=\/UCMCon\/Contribution%20Folders\/WebContent\/pdf\/cp-distal-extrahepatic-bileducts-17protocol-4000.pdf. Accessed November 12, 2017."},{"key":"10.1016\/j.path.2018.02.005_bib4","series-title":"AJCC cancer staging manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.path.2018.02.005_bib5","series-title":"WHO classification of tumours of the digestive system","author":"Bosman","year":"2010"},{"issue":"3","key":"10.1016\/j.path.2018.02.005_bib6","doi-asserted-by":"crossref","first-page":"e0120574","DOI":"10.1371\/journal.pone.0120574","article-title":"Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States","volume":"10","author":"Altekruse","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.path.2018.02.005_bib7","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1007\/s10620-014-3276-2","article-title":"Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification","volume":"59","author":"Tyson","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1016\/j.path.2018.02.005_bib8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/jnci\/djj234","article-title":"Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States","volume":"98","author":"Welzel","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.path.2018.02.005_bib9","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1158\/1055-9965.EPI-05-0811","article-title":"A\u00a0comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States","volume":"15","author":"McGlynn","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"10.1016\/j.path.2018.02.005_bib10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.dld.2009.10.009","article-title":"Descriptive epidemiology of cholangiocarcinoma in Italy","volume":"42","author":"Alvaro","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"14","key":"10.1016\/j.path.2018.02.005_bib11","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0959-8049(03)00544-6","article-title":"Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland","volume":"39","author":"Wood","year":"2003","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.path.2018.02.005_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4251\/wjgo.v2.i11.407","article-title":"Intra-hepatic and extra-hepatic cholangiocarcinoma: new insight into epidemiology and risk factors","volume":"2","author":"Cardinale","year":"2010","journal-title":"World J Gastrointest Oncol"},{"issue":"10","key":"10.1016\/j.path.2018.02.005_bib13","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cgh.2007.05.020","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study","volume":"5","author":"Welzel","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.path.2018.02.005_bib14","first-page":"272","article-title":"Cholangiocarcinoma: increasing burden of classifications","volume":"2","author":"Cardinale","year":"2013","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.path.2018.02.005_bib15","unstructured":"Kakar S, Shi C, Adeyi OA, et\u00a0al. Protocol for the examination of specimens from patients with carcinoma of the intrahepatic bile ducts. 2017. Available at: http:\/\/www.cap.org\/ShowProperty?nodePath=\/UCMCon\/Contribution%20Folders\/WebContent\/pdf\/cp-intrahepatic-bileducts-17protocol-4000.pdf. Accessed November 12, 2017."},{"key":"10.1016\/j.path.2018.02.005_bib16","unstructured":"Kakar S, Shi C, Fitzgibbons P, et\u00a0al. Protocol for the examination of specimens from patients with carcinoma of the perihilar bile ducts. 2017. Available at: http:\/\/www.cap.org\/ShowProperty?nodePath=\/UCMCon\/Contribution%20Folders\/WebContent\/pdf\/cp-perihilar-bileducts-17protocol_4000.pdf. Accessed November 12, 2017."},{"issue":"4","key":"10.1016\/j.path.2018.02.005_bib17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00534-002-0732-8","article-title":"Intrahepatic cholangiocarcinoma: macroscopic type and stage classification","volume":"10","author":"Yamasaki","year":"2003","journal-title":"J\u00a0Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.path.2018.02.005_bib18","series-title":"AJCC cancer staging manual","author":"Edge","year":"2010"},{"issue":"1","key":"10.1016\/j.path.2018.02.005_bib19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1097-0142(197701)39:1<232::AID-CNCR2820390137>3.0.CO;2-Y","article-title":"Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases","volume":"39","author":"Okuda","year":"1977","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.path.2018.02.005_bib20","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/PAS.0000000000000670","article-title":"Distinct clinicopathologic and genetic features of 2 histologic subtypes of intrahepatic cholangiocarcinoma","volume":"40","author":"Hayashi","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.path.2018.02.005_bib21","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","article-title":"Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features","volume":"27","author":"Liau","year":"2014","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.path.2018.02.005_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4254\/wjh.v2.i12.419","article-title":"Pathological classification of intrahepatic cholangiocarcinoma based on a new concept","volume":"2","author":"Nakanuma","year":"2010","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.path.2018.02.005_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/liv.13492","article-title":"Transcriptomic and histopathological analysis of cholangiolocellular differentiation trait in intrahepatic cholangiocarcinoma","volume":"38","author":"Rhee","year":"2018","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.path.2018.02.005_bib24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4251\/wjgo.v4.i5.94","article-title":"Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity","volume":"4","author":"Cardinale","year":"2012","journal-title":"World J Gastrointest Oncol"},{"issue":"2","key":"10.1016\/j.path.2018.02.005_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jhbp.154","article-title":"Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type","volume":"22","author":"Aishima","year":"2015","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"6","key":"10.1016\/j.path.2018.02.005_bib26","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/hep.25595","article-title":"Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes","volume":"55","author":"Komuta","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.path.2018.02.005_bib27","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/modpathol.2011.41","article-title":"Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression","volume":"24","author":"Yu","year":"2011","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.path.2018.02.005_bib28","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1097\/PAS.0000000000000957","article-title":"C-Reactive protein (CRP) is a promising diagnostic immunohistochemical marker for intrahepatic cholangiocarcinoma and is associated with better prognosis","volume":"41","author":"Yeh","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2018.02.005_bib29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1634\/theoncologist.2011-0386","article-title":"Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping","volume":"17","author":"Borger","year":"2012","journal-title":"Oncologist"},{"issue":"12","key":"10.1016\/j.path.2018.02.005_bib30","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/ng.2806","article-title":"Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers","volume":"45","author":"Chan-On","year":"2013","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.path.2018.02.005_bib31","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1016\/j.celrep.2017.02.033","article-title":"Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles","volume":"18","author":"Farshidfar","year":"2017","journal-title":"Cell Rep"},{"issue":"12","key":"10.1016\/j.path.2018.02.005_bib32","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ng.2813","article-title":"Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas","volume":"45","author":"Jiao","year":"2013","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.path.2018.02.005_bib33","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.humpath.2011.12.007","article-title":"Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma","volume":"43","author":"Kipp","year":"2012","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.path.2018.02.005_bib34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1634\/theoncologist.2013-0352","article-title":"New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing","volume":"19","author":"Ross","year":"2014","journal-title":"Oncologist"},{"issue":"25","key":"10.1016\/j.path.2018.02.005_bib35","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1038\/onc.2012.315","article-title":"Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas","volume":"32","author":"Wang","year":"2013","journal-title":"Oncogene"},{"issue":"26","key":"10.1016\/j.path.2018.02.005_bib36","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","article-title":"Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas","volume":"372","author":"Brat","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.path.2018.02.005_bib37","doi-asserted-by":"crossref","first-page":"e1004135","DOI":"10.1371\/journal.pgen.1004135","article-title":"Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma","volume":"10","author":"Borad","year":"2014","journal-title":"PLoS Genet"},{"issue":"12","key":"10.1016\/j.path.2018.02.005_bib38","doi-asserted-by":"crossref","first-page":"e115383","DOI":"10.1371\/journal.pone.0115383","article-title":"Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications","volume":"9","author":"Churi","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.path.2018.02.005_bib39","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.path.2018.02.005_bib40","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1038\/ncomms7087","article-title":"Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma","volume":"6","author":"Sia","year":"2015","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.path.2018.02.005_bib41","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/hep.26890","article-title":"Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma","volume":"59","author":"Arai","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.path.2018.02.005_bib42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/egh.13.3","article-title":"Toward a standardized system for hepatocellular carcinoma diagnosis using computed tomography and MRI","volume":"7","author":"Tang","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.path.2018.02.005_bib43","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/carcin\/bgs208","article-title":"Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFbeta signaling pathways","volume":"33","author":"Coulouarn","year":"2012","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.path.2018.02.005_bib44","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1245\/s10434-014-4247-8","article-title":"The ability to diagnose intrahepatic cholangiocarcinoma definitively using novel branched DNA-enhanced albumin RNA in situ hybridization technology","volume":"23","author":"Ferrone","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.path.2018.02.005_bib45","series-title":"Combined hepatocellular-cholangiocarcinoma. In: WHO classification of tumours of the digestive system","first-page":"225","author":"Theise","year":"2010"},{"issue":"4","key":"10.1016\/j.path.2018.02.005_bib46","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/PAS.0b013e31827332b0","article-title":"Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification","volume":"37","author":"Akiba","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2018.02.005_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29789","article-title":"cHCC-CCA: consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentiation","author":"Brunt","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.path.2018.02.005_bib48","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/PAS.0b013e31820b0603","article-title":"Segmental atrophy of the liver: a distinctive pseudotumor of the liver with variable histologic appearances","volume":"35","author":"Singhi","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2018.02.005_bib49","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/PAS.0000000000000511","article-title":"Nuclear expression of CAMTA1 distinguishes epithelioid hemangioendothelioma from histologic mimics","volume":"40","author":"Doyle","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.path.2018.02.005_bib50","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/gcc.22073","article-title":"Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma","volume":"52","author":"Antonescu","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"10.1016\/j.path.2018.02.005_bib51","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/gcc.20886","article-title":"A\u00a0novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites","volume":"50","author":"Errani","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.path.2018.02.005_bib52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1746-1596-9-131","article-title":"Epithelioid Hemangioendothelioma: clinicopathologic, immunohistochemical, and molecular genetic analysis of 39 cases","volume":"9","author":"Flucke","year":"2014","journal-title":"Diagn Pathol"},{"issue":"10","key":"10.1016\/j.path.2018.02.005_bib53","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/PAS.0b013e318293ddf1","article-title":"Intrabiliary growth of liver metastases: clinicopathologic features, prevalence, and outcome","volume":"37","author":"Estrella","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.path.2018.02.005_bib54","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1053\/j.gastro.2009.02.040","article-title":"A\u00a0multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures","volume":"136","author":"Fritcher","year":"2009","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.path.2018.02.005_bib55","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.humpath.2006.09.004","article-title":"An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas","volume":"38","author":"DeHaan","year":"2007","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.path.2018.02.005_bib56","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","article-title":"Clinical diagnosis and staging of cholangiocarcinoma","volume":"8","author":"Blechacz","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.path.2018.02.005_bib57","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0016-5107(04)01732-8","article-title":"ERCP or EUS for tissue diagnosis of biliary strictures? A prospective comparative study","volume":"60","author":"Rosch","year":"2004","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"10.1016\/j.path.2018.02.005_bib58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2303.2004.00133.x","article-title":"Biliary brushing cytology","volume":"15","author":"Selvaggi","year":"2004","journal-title":"Cytopathology"},{"issue":"26","key":"10.1016\/j.path.2018.02.005_bib59","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.3748\/wjg.14.4131","article-title":"Diagnostic approaches for cholangiocarcinoma","volume":"14","author":"Weber","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.path.2018.02.005_bib60","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cgh.2012.05.025","article-title":"Tissue yield and diagnostic efficacy of fluoroscopic and cholangioscopic techniques to assess indeterminate biliary strictures","volume":"10","author":"Hartman","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.path.2018.02.005_bib61","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1055\/s-0029-1215227","article-title":"Staining for intracytoplasmic lumina and CAM5.2 increases the detection rate for bile duct cancers","volume":"41","author":"Jahng","year":"2009","journal-title":"Endoscopy"},{"issue":"9","key":"10.1016\/j.path.2018.02.005_bib62","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.humpath.2010.01.014","article-title":"S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy","volume":"41","author":"Levy","year":"2010","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.path.2018.02.005_bib63","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/PAI.0b013e318245e05b","article-title":"Use of IMP3, S100P, and pVHL immunopanel to aid in the interpretation of bile duct biopsies with atypical histology or suspicious for malignancy","volume":"20","author":"Schmidt","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"11","key":"10.1016\/j.path.2018.02.005_bib64","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.humpath.2015.07.005","article-title":"Diagnostic value of maspin in distinguishing adenocarcinoma from benign biliary epithelium on endoscopic bile duct biopsy","volume":"46","author":"Chen","year":"2015","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.path.2018.02.005_bib65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10555-016-9645-x","article-title":"HER2\/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?","volume":"36","author":"Galdy","year":"2017","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"10.1016\/j.path.2018.02.005_bib66","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s11605-008-0750-1","article-title":"Fibroinflammatory biliary stricture: a rare bile duct lesion masquerading as cholangiocarcinoma","volume":"13","author":"Gamblin","year":"2009","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.path.2018.02.005_bib67","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12893-017-0214-1","article-title":"Isolated IgG4-related sclerosing cholangitis misdiagnosed as malignancy in an area with endemic cholangiocarcinoma: a case report","volume":"17","author":"Rungsakulkij","year":"2017","journal-title":"BMC Surg"},{"issue":"2","key":"10.1016\/j.path.2018.02.005_bib68","first-page":"170","article-title":"Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver","volume":"140","author":"Bismuth","year":"1975","journal-title":"Surg Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.path.2018.02.005_bib69","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.surg.2009.02.023","article-title":"Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma","volume":"146","author":"Hong","year":"2009","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.path.2018.02.005_bib70","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.pas.0000213384.25042.86","article-title":"Measurement of the invasion depth of extrahepatic bile duct carcinoma: an alternative method overcoming the current T classification problems of the AJCC staging system","volume":"31","author":"Hong","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2018.02.005_bib71","doi-asserted-by":"crossref","first-page":"678260","DOI":"10.1155\/2014\/678260","article-title":"Histological characterization of biliary intraepithelial neoplasia with respect to pancreatic intraepithelial neoplasia","volume":"2014","author":"Sato","year":"2014","journal-title":"Int J Hepatol"},{"issue":"6","key":"10.1016\/j.path.2018.02.005_bib72","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/modpathol.3800788","article-title":"Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria","volume":"20","author":"Zen","year":"2007","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.path.2018.02.005_bib73","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1097\/PAS.0000000000000533","article-title":"A\u00a0revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas","volume":"39","author":"Basturk","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2018.02.005_bib74","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/SLA.0b013e31811f4449","article-title":"Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients","volume":"247","author":"Crippa","year":"2008","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.path.2018.02.005_bib75","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/PAS.0000000000000963","article-title":"Hepatobiliary mucinous cystic neoplasms with ovarian type stroma (So-Called \"Hepatobiliary Cystadenoma\/Cystadenocarcinoma\"): clinicopathologic analysis of 36 cases illustrates rarity of carcinomatous change","volume":"42","author":"Quigley","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2018.02.005_bib76","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MPA.0b013e3181f749d3","article-title":"Clinicopathological features and prognosis of mucinous cystic neoplasm with ovarian-type stroma: a multi-institutional study of the Japan pancreas society","volume":"40","author":"Yamao","year":"2011","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.path.2018.02.005_bib77","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/modpathol.2013.112","article-title":"Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways","volume":"27","author":"Schlitter","year":"2014","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.path.2018.02.005_bib78","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/hep.25786","article-title":"Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?","volume":"56","author":"Rocha","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.path.2018.02.005_bib79","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/PAS.0000000000000782","article-title":"Intraductal tubulopapillary neoplasm of the pancreas: a clinicopathologic and immunohistochemical analysis of 33 cases","volume":"41","author":"Basturk","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.path.2018.02.005_bib80","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/modpathol.2015.61","article-title":"Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases","volume":"28","author":"Schlitter","year":"2015","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.path.2018.02.005_bib81","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.soc.2013.10.005","article-title":"Hilar cholangiocarcinoma","volume":"23","author":"Zaydfudim","year":"2014","journal-title":"Surg Oncol Clin N Am"},{"issue":"8","key":"10.1016\/j.path.2018.02.005_bib82","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/hpb.12441","article-title":"Intrahepatic cholangiocarcinoma: expert consensus statement","volume":"17","author":"Weber","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"2","key":"10.1016\/j.path.2018.02.005_bib83","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5582\/bst.2016.01048","article-title":"The current management of cholangiocarcinoma: a comparison of current guidelines","volume":"10","author":"Cai","year":"2016","journal-title":"Biosci Trends"},{"issue":"4","key":"10.1016\/j.path.2018.02.005_bib84","doi-asserted-by":"crossref","first-page":"298","DOI":"10.5009\/gnl.2009.3.4.298","article-title":"Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or radiotherapy: a large-scale observational study","volume":"3","author":"Park","year":"2009","journal-title":"Gut Liver"},{"issue":"1","key":"10.1016\/j.path.2018.02.005_bib85","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cgh.2012.09.009","article-title":"Classification, diagnosis, and management of cholangiocarcinoma","volume":"11","author":"Razumilava","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.path.2018.02.005_bib86","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/annonc\/mdt540","article-title":"Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials","volume":"25","author":"Valle","year":"2014","journal-title":"Ann Oncol"},{"issue":"14","key":"10.1016\/j.path.2018.02.005_bib87","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.path.2018.02.005_bib88","unstructured":"National Comprehensive Cancer Network. Hepatobiliary cancer (Version 4.2017). Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hepatobiliary.pdf. Accessed November 14, 2017."},{"issue":"2","key":"10.1016\/j.path.2018.02.005_bib89","doi-asserted-by":"crossref","first-page":"293","DOI":"10.21037\/jgo.2016.10.01","article-title":"Biliary cancer: intrahepatic cholangiocarcinoma vs. extrahepatic cholangiocarcinoma vs. gallbladder cancers: classification and therapeutic implications","volume":"8","author":"Ahn","year":"2017","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"74","key":"10.1016\/j.path.2018.02.005_bib90","first-page":"41","article-title":"Toward personalized treatment of advanced biliary tract cancers","volume":"14","author":"Geynisman","year":"2012","journal-title":"Discov Med"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918118300059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918118300059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T16:55:00Z","timestamp":1661187300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918118300059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1875918118300059"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2018.02.005","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2018.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}